On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
MNAR
.
Show all posts
Showing posts with label
MNAR
.
Show all posts
Thursday, January 01, 2026
One-way versus two-way tipping point analysis for robustness assessment of the missing data
›
Tipping point analysis (TPA) is a key sensitivity analysis mandated by regulatory agencies like the FDA to assess the robustness of clinic...
›
Home
View web version